Shanghai, China · Founded 2015 · In IPO Registration
Researcher and developer of innovative drugs focused on oncology treatments. Convalife Pharmaceuticals is based in Shanghai, China and was founded in 2015. Its last reported valuation was $445 million in Jul 2025. It has raised $59.8 million.
Last reported valuation
$444.6M
Oct 2026
Priced at
—
Total raised
$59.8M
Last round
—
Team — not yet on record
No current team members for Convalife Pharmaceuticals are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Convalife Pharmaceuticals with a free account
·The complete investor list: 12 names
·Watch Convalife Pharmaceuticals: the Monday email on marks, rounds and moves
